This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 May;8(3):271-2.

doi: 10.1586/17512433.2015.1041850.

Bevacizumab-associated diverticulitis: results of disproportionality analysis

Manfred Hauben¹, Eric Hung

Affiliations

PMID: 25916664
DOI: 10.1586/17512433.2015.1041850

Comment

Bevacizumab-associated diverticulitis: results of disproportionality analysis

Manfred Hauben et al. Expert Rev Clin Pharmacol. 2015 May.

. 2015 May;8(3):271-2.

doi: 10.1586/17512433.2015.1041850.

Authors

Manfred Hauben¹, Eric Hung

Affiliation

¹ Pfizer, Inc., New York, NY, USA.

PMID: 25916664
DOI: 10.1586/17512433.2015.1041850

No abstract available

PubMed Disclaimer

Comment on

Adverse reactions to oncologic drugs: spontaneous reporting and signal detection.
Tuccori M, Montagnani S, Capogrosso-Sansone A, Mantarro S, Antonioli L, Fornai M, Blandizzi C. Tuccori M, et al. Expert Rev Clin Pharmacol. 2015 Jan;8(1):61-75. doi: 10.1586/17512433.2015.974555. Epub 2014 Nov 3. Expert Rev Clin Pharmacol. 2015. PMID: 25363790 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information